Silymarin nanoemulsion against human hepatocellular carcinoma: development and optimization

References

• Karkanis A, Bilalis D, Efthimiadou A. Cultivation of milk thistle (Silybum marianum L. Gaertn.), a medicinal weed. Ind Crops Prod. 2011;34:825–830.
   Web of Science ®Google Scholar
• Ligeret H, Brault A, Vallerand D, et al. Antioxidant and mitochondrial protective effects of silibinin in cold preservation–warm reperfusion liver injury. J Ethnopharmacol. 2008;115:507–514.
   PubMed Web of Science ®Google Scholar
• Kim S, Choi MG, Lee HS, et al. Silibinin suppresses TNF-α-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway. Molecules. 2009;14:4300–4311.
   PubMed Web of Science ®Google Scholar
• Dixit N, Baboota S, Kohli K, et al. Silymarin: a review of pharmacological aspects and bioavailability enhancement approaches. Indian J Pharmacol. 2007;39:172.
   Web of Science ®Google Scholar
• Ahmad U, Faiyazuddin M, Hussain MT, et al. Silymarin: an insight to its formulation and analytical prospects. Acta Physiol Plant. 2015;37:1–7.
   Web of Science ®Google Scholar
• Javed S, Kohli K, Ali M. Reassessing bioavailability of silymarin. Altern Med Rev. 2011;16:239–249.
   PubMed Web of Science ®Google Scholar
• Shi J, Votruba AR, Farokhzad OC, et al. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett. 2010;10:3223–3230.
   PubMed Web of Science ®Google Scholar
• Wagner V, Dullaart A, Bock AK, et al. The emerging nanomedicine landscape. Nat Biotechnol. 2006;24:1211–1217.
   PubMed Web of Science ®Google Scholar
• Zhang P, Ye H, Min T, et al. Water soluble poly (ethylene glycol) prodrug of silybin: design, synthesis, and characterization. J Appl Polym Sci. 2008;107:3230–3235.
   Web of Science ®Google Scholar
• Jain KK. The handbook of nanomedicine. New York: Springer Science and Business Media; 2012.
   Google Scholar
• Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci. 1993;82:979–987.
   PubMed Web of Science ®Google Scholar
• Burcham DL, Maurin MB, Hausner EA, et al. Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. Biopharmaceutics Biopharm Drug Dispos. 1997;18:737–742.
   PubMed Web of Science ®Google Scholar
• Serajuddin A, Sheen PC, Mufson D, et al. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water‐soluble drug from solid dispersions. J Pharm Sci. 1988;77:414–417.
   PubMed Web of Science ®Google Scholar
• Serajuddin A. Solid dispersion of poorly water‐soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88:1058–1066.
   PubMed Web of Science ®Google Scholar
• Aungst BJ, Nguyen N, Rogers NJ, et al. Improved oral bioavailability of an HIV protease inhibitor using Gelucire 44/14 and Labrasol vehicles. BT Gattefosse. 1994;87:49–54.
   Google Scholar
• Toguchi H, Ogawa Y, Iga K, et al. Effects of physiological factors on the bioavailability of ethyl 2-chloro-3-[4-(2-methyl-2-phenylpropyloxy) phenyl] propionate in an emulsion in rats. Chem Pharm Bull. 1990;38:2801–2804.
   PubMed Web of Science ®Google Scholar
• Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63:288–294.
   PubMed Web of Science ®Google Scholar
• Stella V, Haslam J, Yata N, et al. Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule. J Pharm Sci. 1978;67:1375–1377.
   PubMed Web of Science ®Google Scholar
• Kararli TT, Needham TE, Griffin M, et al. Oral delivery of a renin inhibitor compound using emulsion formulations. Pharm Res. 1992;9:888–893.
   PubMed Web of Science ®Google Scholar
• Myers RA, Stella VJ. Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int J Pharm. 1992;78:217–226.
   Web of Science ®Google Scholar
• Palin KJ, Phillips AJ, Ning A. The oral absorption of cefoxitin from oil and emulsion vehicles in rats. Int J Pharm. 1986;33:99–104.
   Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89–121.
   PubMed Web of Science ®Google Scholar
• Akhtar J, Siddiqui HH, Fareed S, et al. Nanoemulsion: for improved oral delivery of repaglinide. Drug Deliv. 2016;23:2026–2034.
   PubMed Web of Science ®Google Scholar
• Jadhav KR, Shaikh IM, Ambade KW, et al. Applications of microemulsion based drug delivery system. Curr Drug Deliv. 2006;3:267–273.
   PubMedGoogle Scholar
• Schwendener RA, Schott H. Lipophilic 1-β-d-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model. J Cancer Res Clin Oncol. 1996;122:723–726.
   PubMed Web of Science ®Google Scholar
• Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, et al. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech. 2007;8:E12.7.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165–196.
   PubMed Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66:227–243.
   PubMed Web of Science ®Google Scholar
• Kommuru TR, Gurley B, Khan MA, et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212:233–246.
   PubMed Web of Science ®Google Scholar
• Akhtar J. Novel oral nanoemulsion based drug delivery system of antidiabetic drugs [dissertation]. Lucknow, India: Integral University; 2015.
   Google Scholar
• Parveen R, Ahmad S, Baboota S, et al. Stability‐indicating HPTLC method for quantitative estimation of silybin in bulk drug and pharmaceutical dosage form. Biomed Chromatogr. 2010;24:639–647.
   PubMed Web of Science ®Google Scholar
• Akhtar J, Hussain Siddiqui H, Fareed S, et al. Nanomulsion as a carrier for efficient delivery of metformin. Curr Drug Deliv. 2014;11:243–252.
   PubMed Web of Science ®Google Scholar
• Fraga M, Laux M, Rejane dos Santos G, et al. Evaluation of the toxicity of oligonucleotide/cationic nanoemulsion complexes on Hep G2 cells through MTT assay. Die Pharmazie-Int J Pharm Sci. 2008;63:667–670.
   Google Scholar
• Siddiqui S, Ahmad E, Gupta M, et al. Cissus quadrangularis Linn exerts dose‐dependent biphasic effects: osteogenic and anti‐proliferative, through modulating ROS, cell cycle and Runx2 gene expression in primary rat osteoblasts. Cell Prolif. 2015;48:443–454.
   PubMed Web of Science ®Google Scholar
• Kaleem S, Siddiqui S, Siddiqui HH, et al. Eupalitin induces apoptosis in prostate carcinoma cells through ROS generation and increase of caspase‐3 activity. Cell Biol Int. 2016;40:196–203.
   PubMed Web of Science ®Google Scholar
• Parveen R, Baboota S, Ali J, et al. Oil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studies. Int J Pharm. 2011;413:245–253.
   PubMed Web of Science ®Google Scholar
• Calligaris S, Comuzzo P, Bot F, et al. Nanoemulsions as delivery systems of hydrophobic silybin from silymarin extract: effect of oil type on silybin solubility, in vitro bioaccessibility and stability. LWT – Food Sci Technol. 2015;63:77–84.
   Web of Science ®Google Scholar
• Adhikari M, Arora R. Nano-silymarin provides protection against γ-radiation-induced oxidative stress in cultured human embryonic kidney cells. Mutat Res/Genet Toxicol Environ Mutagen. 2015;792:1–11.
   PubMed Web of Science ®Google Scholar
• Woo JS, Kim TS, Park JH, et al. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS. Arch Pharm Res. 2007;30:82–89.
   PubMed Web of Science ®Google Scholar
• Kumar N, Rai A, Reddy ND, et al. Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells. Pharmacol Rep. 2014;66:788–798.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan G, Lo Muzio L, Elinos, et al. Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Prolif. 2009;42:229–240.
   PubMed Web of Science ®Google Scholar
• Fleury C, Mignotte B, Vayssière JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002;84:131–141.
   PubMed Web of Science ®Google Scholar
• Chibber S, Farhan M, Hassan I, et al. Novel aspect of chemophototherapy in treatment of cancer. Tumour Biol. 2012;33:701–706.
   PubMed Web of Science ®Google Scholar